The pharmaceutical community is buzzing about Retatrutide 120 , a dual-action medication showing remarkable outcomes in clinical trials . This new compound, a glucagon-like peptide-1 receptor alongside a similar molecule , appears to notably decrease body size and enhance metabolic health . Clinicians are proposing that it has the potential to offe